Published in Neuropharmacology on January 01, 1986
Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology (Berl) (2004) 2.02
The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology (Berl) (2007) 1.74
Effect of fenfluramine on reinstatement of food seeking in female and male rats: implications for the predictive validity of the reinstatement model. Psychopharmacology (Berl) (2011) 0.98
The effects of yohimbine and amphetamine on fear expression and extinction in rats. Psychopharmacology (Berl) (2009) 0.92
Inactivation of the nucleus accumbens core or medial shell attenuates reinstatement of sugar-seeking behavior following sugar priming or exposure to food-associated cues. PLoS One (2014) 0.85
Effect of yohimbine on reinstatement of operant responding in rats is dependent on cue contingency but not food reward history. Addict Biol (2014) 0.82
A re-evaluation of the role of alpha 2-adrenoceptors in the anxiogenic effects of yohimbine, using the selective antagonist delequamine in the rat. Br J Pharmacol (1995) 0.81
Differential behavioral responses of zebrafish larvae to yohimbine treatment. Psychopharmacology (Berl) (2014) 0.77
Enhanced motivation for food reward induced by stress and attenuation by corticotrophin-releasing factor receptor antagonism in rats: implications for overeating and obesity. Psychopharmacology (Berl) (2014) 0.76
Yohimbine is a 5-HT1A agonist in rats in doses exceeding 1mg/kg. Neurosci Lett (2015) 0.75
Effect of yohimbine stress on reacquisition of oxycodone seeking in rats. Psychopharmacology (Berl) (2012) 0.75
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods (1985) 9.05
Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav (1986) 2.73
Effects of moderate alcohol consumption on the central nervous system. Alcohol Clin Exp Res (1998) 2.60
Can social interaction be used to measure anxiety? Br J Pharmacol (1978) 2.50
Validity of head-dipping as a measure of exploration in a modified hole-board. Psychopharmacologia (1975) 2.46
The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Methods (1980) 2.26
Sex differences in animal tests of anxiety. Physiol Behav (1991) 1.74
The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol Biochem Behav (1996) 1.39
Factor analysis shows that female rat behaviour is characterized primarily by activity, male rats are driven by sex and anxiety. Pharmacol Biochem Behav (1999) 1.26
5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Res (1996) 1.25
Do lorazeam-induced deficits in learning result from impaired rehearsal, reduced motivation or increased sedation? Br J Clin Pharmacol (1982) 1.20
Nicotine self-administration and withdrawal: modulation of anxiety in the social interaction test in rats. Psychopharmacology (Berl) (2001) 1.13
The reliability of the hole-board apparatus. Psychopharmacologia (1975) 1.11
Corticotropin-releasing factor has an anxiogenic action in the social interaction test. Horm Behav (1987) 1.11
Effects of ethanol and chlordiazepoxide on social interaction in rats [proceedings]. Br J Pharmacol (1976) 1.10
Studies on the role of ACTH and of 5-HT in anxiety, using an animal model. J Pharm Pharmacol (1978) 1.10
Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release. J Neurochem (2000) 1.08
Behavioral consequences in animal tests of anxiety and exploration of exposure to cat odor. Brain Res Bull (1992) 1.07
Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety. Eur J Pharmacol (1993) 1.07
Impaired performance and sedation after a single dose of lorazepam. Psychopharmacology (Berl) (1979) 1.03
Evidence that the median raphé nucleus--dorsal hippocampal pathway mediates diazepam withdrawal-induced anxiety. Psychopharmacology (Berl) (1997) 1.03
Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. Behav Pharmacol (1999) 1.00
Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal. Pharmacol Biochem Behav (2001) 1.00
The dorsal raphé nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses. Psychopharmacology (Berl) (2001) 0.99
Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats. Behav Pharmacol (2004) 0.98
Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788. Psychopharmacology (Berl) (1986) 0.98
Antagonistic effects of caffeine and yohimbine in animal tests of anxiety. Eur J Pharmacol (1989) 0.97
Interaction between effects of caffeine and lorazepam in performance tests and self-ratings. J Clin Psychopharmacol (1982) 0.97
The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard. Br J Pharmacol (1985) 0.97
Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites. Pharmacol Biochem Behav (1989) 0.95
Multiple sites of action for anxiogenic drugs: behavioural, electrophysiological and biochemical correlations. Psychopharmacology (Berl) (1984) 0.95
Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res Mol Brain Res (2000) 0.95
Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine. Psychopharmacology (Berl) (1999) 0.94
Corticosterone -- an anxiogenic or an anxiolytic agent? J Pharm Pharmacol (1979) 0.94
Stimulation of benzodiazepine receptors in the dorsal hippocampus and median raphé reveals differential GABAergic control in two animal tests of anxiety. Eur J Neurosci (1998) 0.94
The anxiogenic action of benzodiazepine antagonists. Neuropharmacology (1982) 0.94
Selectively bred lines of rats differ in social interaction and hippocampal 5-HT1A receptor function: a link between anxiety and depression? Pharmacol Biochem Behav (1998) 0.93
Sedative effects of PK 9084 and PK 8165, alone and in combination with chlordiazepoxide. Br J Pharmacol (1983) 0.93
Aversive and appetitive properties of anxiogenic and anxiolytic agents. Behav Brain Res (1986) 0.93
Mice lacking the cell adhesion molecule Thy-1 fail to use socially transmitted cues to direct their choice of food. Curr Biol (2000) 0.92
Do the reductions in social interaction produced by picrotoxin and pentylenetetrazole indicate anxiogenic actions? Neuropharmacology (1984) 0.92
Methodological considerations in neurobehavioral teratology. Pharmacol Biochem Behav (1996) 0.92
Effects of two anxiolytics on distraction, habituation and dishabitiuation. Pharmacol Biochem Behav (1977) 0.91
5-HT1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur J Pharmacol (1994) 0.91
Decreased 5-HT1A and increased 5-HT2A receptor binding after chronic corticosterone associated with a behavioural indication of depression but not anxiety. Psychoneuroendocrinology (1997) 0.91
Regional differences in rat benzodiazepine binding in response to novelty and cat odour. Neuropharmacology (1994) 0.90
On the convulsant action of Ro 5-4864 and the existence of a micromolar benzodiazepine binding site in rat brain. Psychopharmacology (Berl) (1984) 0.90
The effects of piracetam on acquisition and retention of habituation [proceedings]. Br J Pharmacol (1977) 0.90
Tolerance to the anti-pentylenetetrazole effects of diazepam in the mouse. Psychopharmacology (Berl) (1983) 0.90
Pharmacokinetic studies on Ro 15-1788, a benzodiazepine receptor ligand, in the brain of the rat. Brain Res (1984) 0.90
Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat. J Pharm Pharmacol (1987) 0.90
The effect of treatment regimen on the development of tolerance to the sedative and anxiolytic effects of diazepam. Psychopharmacology (Berl) (1999) 0.89
A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus. J Neurosci (1997) 0.89
Antagonism of the anxiolytic effect of nicotine in the dorsal raphe nucleus by dihydro-beta-erythroidine. Pharmacol Biochem Behav (2001) 0.89
A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquilisers and of stimulants. Pharmacol Biochem Behav (1979) 0.89
Nicotine regulates 5-HT(1A) receptor gene expression in the cerebral cortex and dorsal hippocampus. Eur J Neurosci (2001) 0.89
Acute and chronic effects of three benzodiazepines in the social interaction anxiety test in mice. Psychopharmacology (Berl) (1979) 0.88
Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of alpha7 receptors. Neuropharmacology (2003) 0.88
Rapid development of tolerance to the sedative effects of lorazepam and triazolam in rats. Psychopharmacology (Berl) (1981) 0.88
Tolerance to the behavioral actions of benzodiazepines. Neurosci Biobehav Rev (1985) 0.88
Animal models for predicting clinical efficacy of anxiolytic drugs: social behaviour. Neuropsychobiology (1985) 0.88
Recovery from lorazepam tolerance and the effects of a benzodiazepine antagonist (RO 15-1788) on the development of tolerance. Psychopharmacology (Berl) (1982) 0.88
Chlordiazepoxide reduces the generalised anxiety, but not the direct responses, of rats exposed to cat odor. Pharmacol Biochem Behav (1992) 0.87
In adolescence, female rats are more sensitive to the anxiolytic effect of nicotine than are male rats. Neuropsychopharmacology (2001) 0.87
What can be learned from the effects of benzodiazepines on exploratory behavior? Neurosci Biobehav Rev (1985) 0.87
Benzodiazepines reduce gastric ulcers induced in rats by stress. Br J Pharmacol (1981) 0.86
Caffeine-induced anxiogenesis: the role of adenosine, benzodiazepine and noradrenergic receptors. Pharmacol Biochem Behav (1989) 0.86
5-HT and anxiety: promises and pitfalls. Pharmacol Biochem Behav (1986) 0.86
The role of 5-HT1A receptors in mediating the anxiogenic effects of nicotine following lateral septal administration. Eur J Neurosci (2000) 0.85
Anxiogenic effects of nicotine in the dorsal hippocampus are mediated by 5-HT1A and not by muscarinic M1 receptors. Neuropharmacology (2000) 0.85
Hippocampal and septal injections of nicotine and 8-OH-DPAT distinguish among different animal tests of anxiety. Prog Neuropsychopharmacol Biol Psychiatry (2000) 0.85
Behavioural and neurochemical responses of male and female chicks to cat odour. Pharmacol Biochem Behav (1996) 0.85
Responders and nonresponders to cat odor do not differ in other tests of anxiety. Pharmacol Biochem Behav (1994) 0.84
Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety. Eur J Neurosci (1999) 0.84
Cold restraint alters dopamine metabolism in frontal cortex, nucleus accumbens and neostriatum. Physiol Behav (1983) 0.84
The effects of tricyclic and 'atypical' antidepressants on spontaneous locomotor activity in rodents. Neurosci Biobehav Rev (1986) 0.83
Changes in tonic immobility and the GABA-benzodiazepine system in response to handling in the chick. Pharmacol Biochem Behav (1997) 0.83
5,7-dihydroxytryptamine lesions of dorsal and median raphé nuclei and performance in the social interaction test of anxiety and in a home-cage aggression test. J Affect Disord (1979) 0.83
The sensitivity of the rat corticosterone response to environmental manipulations and to chronic chlordiazepoxide treatment. Physiol Behav (1980) 0.83
Benzodiazepines reduce stress-augmented increase in rat urine monoamine oxidase inhibitor. Nature (1981) 0.83
Dose tolerance to lorazepam develop with once weekly dosing? Br J Clin Pharmacol (1983) 0.83
Cognitive impairments of alcoholic cirrhotic patients: correlation with endogenous benzodiazepine receptor ligands and increased affinity of platelet receptors. J Neurol Neurosurg Psychiatry (1996) 0.83
The effects of putative anxiogenic compounds (FG 7142, CGS 8216 and Ro 15-1788) on the rat corticosterone response. Physiol Behav (1985) 0.83
Contrasting behavioural effects of 8-OH DPAT in the dorsal raphé nucleus and ventral hippocampus. Neuropharmacology (1994) 0.83
Anxiolytic and anxiogenic drug effects in a novel test of anxiety: are exploratory models of anxiety in rodents valid? Methods Find Exp Clin Pharmacol (1986) 0.83
Reversal of increased anxiety during benzodiazepine withdrawal: evidence for an anxiogenic endogenous ligand for the benzodiazepine receptor. Brain Res Bull (1988) 0.83
Does the sedation resulting from sleep deprivation and lorazepam cause similar cognitive deficits? Pharmacol Biochem Behav (1998) 0.83
Sex differences in benzodiazepine binding in the frontal cortex and amygdala of the rat 24 hours after restraint stress. Neurosci Lett (1996) 0.83
The locus coeruleus noradrenergic system--evidence against a role in attention, habituation, anxiety and motor activity. Brain Res (1978) 0.82
Raised [3H]-5-HT release and 45Ca2+ uptake in diazepam withdrawal: inhibition by baclofen. Pharmacol Biochem Behav (1992) 0.82
Are the anxiogenic effects of yohimbine mediated by its action at benzodiazepine receptors? Neurosci Lett (1985) 0.82